These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17646401)

  • 1. The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease.
    Gentry MS; Dowen RH; Worby CA; Mattoo S; Ecker JR; Dixon JE
    J Cell Biol; 2007 Jul; 178(3):477-88. PubMed ID: 17646401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism.
    Gentry MS; Pace RM
    BMC Evol Biol; 2009 Jun; 9():138. PubMed ID: 19545434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique evolution of the carbohydrate-binding module CBM20 in laforin.
    Kuchtová A; Gentry MS; Janeček Š
    FEBS Lett; 2018 Feb; 592(4):586-598. PubMed ID: 29389008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli.
    Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS
    BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
    Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
    Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
    Dubey D; Ganesh S
    Hum Mol Genet; 2008 Oct; 17(19):3010-20. PubMed ID: 18617530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
    Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
    Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
    Srikumar PS; Rohini K
    Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical characterization of laforin-carbohydrate interaction.
    Dias DM; Furtado J; Wasielewski E; Cruz R; Costello B; Cole L; Faria TQ; Baaske P; Brito RM; Ciulli A; Simões I; Macedo-Ribeiro S; Faro C; Geraldes CF; Castanheira P
    Biochem J; 2016 Feb; 473(3):335-45. PubMed ID: 26578817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Biological Activity of the Glucan Phosphatase Laforin.
    Romá-Mateo C; Raththagala M; Gentry MS; Sanz P
    Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
    Singh S; Satishchandra P; Shankar SK; Ganesh S
    Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
    Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.